The acute and chronic effects of (+) and (-) oxaprotiline upon melatonin secretion in normal subjects

Psychol Med. 1992 Feb;22(1):61-7. doi: 10.1017/s0033291700032736.

Abstract

Ten healthy male subjects were treated for three weeks with (+)oxaprotiline, a selective inhibitor of noradrenaline (NA) uptake and with (-)oxaprotiline which does not inhibit NA uptake. Plasma melatonin concentrations were measured throughout the night at 0, 1, 7 and 21 days and were higher during treatment with (+)oxaprotiline than with (-)oxaprotiline for the entire three weeks of treatment. Since NA stimulates the production and secretion of melatonin, these results are consistent with a sustained increase in noradrenergic activity within the pineal, during 21 days of treatment with an effective NA uptake inhibitor.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Adult
  • Antidepressive Agents / pharmacology*
  • Double-Blind Method
  • Humans
  • Male
  • Maprotiline / analogs & derivatives*
  • Maprotiline / pharmacology
  • Melatonin / blood*
  • Norepinephrine / physiology
  • Pineal Gland / drug effects
  • Pineal Gland / physiology
  • Receptors, Adrenergic / drug effects
  • Receptors, Adrenergic / physiology
  • Stereoisomerism

Substances

  • Antidepressive Agents
  • Receptors, Adrenergic
  • Maprotiline
  • hydroxymaprotilin
  • Melatonin
  • Norepinephrine